Baricitinib
Severe
Database
Drug interaction classified as: others
Source: DDInter
Drug reference
alefacept
Anti-CD2 monoclonal antibody · Immunosuppressant
Anti-CD2 monoclonal antibodyImmunosuppressant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- BaricitinibSevereDatabaseDDInter
- CladribineSevereDatabaseDDInter
- FingolimodSevereDatabaseDDInter
- LeflunomideSevereDatabaseDDInter
Mechanism
Human LFA-3–IgG1 fusion protein. The LFA-3 portion of alefacept binds to CD2 on T lymphocytes, blocking the interaction between LFA-3 and CD2 and interfering with T-cell activation.
Indications
psoriasis
Drug interactions
Cladribine
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Fingolimod
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Leflunomide
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Measles Virus Vaccine Live Attenuated
Severe
Database
Drug interaction classified as: others
Source: DDInter
Mumps Virus Strain B Level Jeryl Lynn Live Antigen
Severe
Database
Drug interaction classified as: others
Source: DDInter
Natalizumab
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Ozanimod
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Rotavirus Vaccine
Severe
Database
Drug interaction classified as: others
Source: DDInter
Rubella Virus Vaccine
Severe
Database
Drug interaction classified as: others
Source: DDInter
Siponimod
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Talimogene Laherparepvec
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Related guidelines
Ask House about alefacept
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team